文献速递胸部CT

中国武汉62例新型冠状病毒肺炎(COVID-19)的CT特征

CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China.
PubMed 文献 · AJR Am J Roentgenol · 2020-03-05

回顾性分析武汉62例实验室确诊COVID-19肺炎的CT特征,多数表现为多发病灶、外周分布为主,中下肺及后部CT评分更高;进展期(症状出现8-14天)较早期(≤7天)出现更多网格状磨玻璃影、空泡征、纤维条索、胸膜下线、支气管充气征、支气管扭曲及胸腔积液,而单纯磨玻璃影减少。

要点

  • 62例中83.9%首诊CT见多发病灶,77.4%以周围分布为主。
  • 上肺区CT评分3.0±3.4,低于中肺区4.5±3.8和下肺区4.5±3.7(p=0.022和p=0.020)。
  • 前部CT评分4.4±4.1,低于后部7.7±6.3(p=0.003)。

核心结论

  • COVID-19肺炎CT表现多样,肺实质与肺间质均受累;首诊CT见磨玻璃影和单发病灶提示早期病变,进展期加重与修复征象共存,病灶特征性分布于中下肺及后部肺区。

研究设计与样本

  • 回顾性研究,连续纳入62例实验室确诊COVID-19肺炎患者,由两名胸部放射科医师评估病灶分布和CT征象并评分。

关键影像表现/征象

  • CT征象发生率:磨玻璃影40.3%(25/62)、实变33.9%(21/62)、磨玻璃影伴网格状图案62.9%(39/62)、空泡征54.8%(34/62)、微血管扩张征45.2%(28/62)、纤维条索56.5%(35/62)、胸膜下线33.9%(21/62)、胸膜下透明线53.2%(33/62)。
  • 支气管改变:支气管充气征72.6%(45/62)、支气管扭曲17.7%(11/62);胸膜改变:胸膜增厚48.4%(30/62)、胸膜牵拉征56.5%(35/62)、胸腔积液9.7%(6/62)。
  • 与早期(症状出现≤7天)相比,进展期(症状出现8-14天)磨玻璃影伴网格状图案、空泡征、纤维条索、胸膜下线、胸膜下透明线、支气管充气征、支气管扭曲及胸腔积液的出现频率显著增加,而磨玻璃影显著减少。

诊断标准与关键数值

  • 上肺区平均CT评分3.0±3.4,显著低于中肺区4.5±3.8(p=0.022)和下肺区4.5±3.7(p=0.020);中肺区与下肺区CT评分差异无统计学意义(p=1.00)。
  • 前部平均CT评分4.4±4.1,显著低于后部7.7±6.3(p=0.003)。

临床应用与阅片要点

  • 首诊CT见磨玻璃影和单发病灶提示早期COVID-19肺炎。
  • 进展期COVID-19肺炎可同时见加重与修复征象,病灶多分布于中下肺及后部肺区。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to investigate 62 subjects in Wuhan, China, with laboratory-confirmed coronavirus disease (COVID-19) pneumonia and describe the CT features of this epidemic disease. MATERIALS AND METHODS. A retrospective study of 62 consecutive patients with laboratory-confirmed COVID-19 pneumonia was performed. CT images and clinical data were reviewed. Two thoracic radiologists evaluated the distribution and CT signs of the lesions and also scored the extent of involvement of the CT signs. The Mann-Whitney U test was used to compare lesion distribution and CT scores. The chi-square test was used to compare the CT signs of early-phase versus advanced-phase COVID-19 pneumonia. RESULTS. A total of 62 patients (39 men and 23 women; mean [± SD] age, 52.8 ± 12.2 years; range, 30-77 years) with COVID-19 pneumonia were evaluated. Twenty-four of 30 patients who underwent routine blood tests (80.0%) had a decreased lymphocyte count. Of 27 patients who had their erythrocyte sedimentation rate and high-sensitivity C-reactive protein level assessed, 18 (66.7%) had an increased erythrocyte sedimentation rate, and all 27 (100.0%) had an elevated high-sensitivity C-reactive protein level. Multiple lesions were seen on the initial CT scan of 52 of 62 patients (83.9%). Forty-eight of 62 patients (77.4%) had predominantly peripheral distribution of lesions. The mean CT score for the upper zone (3.0 ± 3.4) was significantly lower than that for the middle (4.5 ± 3.8) and lower (4.5 ± 3.7) zones (p = 0.022 and p = 0.020, respectively), and there was no significant difference in the mean CT score of the middle and lower zones (p = 1.00). The mean CT score for the anterior area (4.4 ± 4.1) was significantly lower than that for the posterior area (7.7 ± 6.3) (p = 0.003). CT findings for the patients were as follows: 25 patients (40.3%) had ground-glass opacities (GGO), 21 (33.9%), consolidation; 39 (62.9%), GGO plus a reticular pattern; 34 (54.8%), vacuolar sign; 28 (45.2%), microvascular dilation sign; 35 (56.5%), fibrotic streaks; 21 (33.9%), a subpleural line; and 33 (53.2%), a subpleural transparent line. With regard to bronchial changes seen on CT, 45 patients (72.6%) had air bronchogram, and 11 (17.7%) had bronchus distortion. In terms of pleural changes, CT showed that 30 patients (48.4%) had pleural thickening, 35 (56.5%) had pleural retraction sign, and six (9.7%) had pleural effusion. Compared with early-phase disease (≤ 7 days after the onset of symptoms), advanced-phase disease (8-14 days after the onset of symptoms) was characterized by significantly increased frequencies of GGO plus a reticular pattern, vacuolar sign, fibrotic streaks, a subpleural line, a subpleural transparent line, air bronchogram, bronchus distortion, and pleural effusion; however, GGO significantly decreased in advanced-phase disease. CONCLUSION. CT examination of patients with COVID-19 pneumonia showed a mixed and diverse pattern with both lung parenchyma and the interstitium involved. Identification of GGO and a single lesion on the initial CT scan suggested early-phase disease. CT signs of aggravation and repair coexisted in advanced-phase disease. Lesions presented with a characteristic multifocal distribution in the middle and lower lung regions and in the posterior lung area. A decreased lymphocyte count and an increased high-sensitivity C-reactive protein level were the most common laboratory findings.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Zhou S, Wang Y, Zhu T, et al. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. AJR Am J Roentgenol. 2020. PMID: 32134681. doi:10.2214/AJR.20.22975

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。